GlassScriptPhysician profile
David M Mcfaddin
NPI 1487666129
$1,521.09
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $802 · 2020: $28.22 · 2021: $36.27 · 2022: $159 · 2023: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306 · Travel and Lodging: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.17 |
| Travel and Lodging | $190.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $527.98 | 2019 | |
| Leica Microsystems INC. | $396.10 | 2020-2023 | |
| Genentech USA, INC. | $148.84 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $148.61 | 2022-2023 | Imfinzi |
| Ipsen Biopharmaceuticals, INC | $124.99 | 2019 | |
| Eisai INC. | $92.55 | 2023 | |
| Innocoll Pharmaceuticals Limited | $33.63 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $23.79 | 2021 | |
| Boston Scientific Corporation | $12.48 | 2021 | |
| Davol INC. | $12.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mcfaddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.